MRCY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Mercury Systems Inc (MRCY) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the technical indicators show a bullish trend and analysts have mixed ratings with some positive price target revisions, the company's financial performance is weak, with declining net income, EPS, and gross margins. Additionally, hedge funds are selling the stock, and there are no recent news catalysts or significant insider activity to support a strong buy decision. The options data also does not indicate strong bullish sentiment.
The technical indicators for MRCY are bullish. The MACD is positive and expanding, the RSI is in the neutral zone at 60.638, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 89.879) in pre-market at 89.52, suggesting limited immediate upside.
Analysts from RBC, Truist, and Canaccord have raised price targets and maintained Buy ratings following a strong Q2 earnings beat.
The company is focused on improving working capital and accelerating customer deliveries, which could support future growth.
Hedge funds are selling the stock, with a significant increase in selling activity (387.56% over the last quarter).
Financial performance is weak, with declining net income (-14.13% YoY), EPS (-16.67% YoY), and gross margin (-1.75% YoY).
No recent news or significant insider activity to drive positive sentiment.
In Q2 2026, Mercury Systems reported revenue growth of 4.37% YoY to $232.87M. However, net income dropped by 14.13% YoY to -$15.1M, EPS declined by 16.67% YoY to -$0.25, and gross margin decreased by 1.75% YoY to 21.87%.
Analysts have mixed ratings on MRCY. RBC, Truist, and Canaccord raised price targets to $105, $109, and $102, respectively, citing strong Q2 earnings and operational improvements. However, Jefferies lowered its price target to $85, highlighting low-single-digit growth guidance and reduced margin estimates. Goldman Sachs maintains a Sell rating with a price target of $55, citing risks to margins and elevated valuations.
